This story is intended to provide scientific information without engaging in the controversy over vaccinations. Researchers at the University of Calgary report immunization to prevent RSV in infants reduced ICU hospital admissions by ninety-seven percent. Statistics from two Canadian provinces, published in JAMA Network Open, show babies in their first year are particularly vulnerable to the virus. Authors say results were dramatic—that the RSV vaccine showed seventy-nine percent protection against hospitalization, in addition to near total protection against being admitted to an Intensive Care Unit. They note most of the babies with RSV infections were otherwise healthy, reinforcing the value of a universal approach to RSV protection.